Abvc Biopharma ABVC
NASDAQ ABVC
$1.02 -0.04 (-3.77%)
At close: Oct 1, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Return on Equity [ROE] (2015 - 2026)

Updated

Abvc Biopharma (ABVC) posted Return on Equity [ROE] of -60.57% for Q2 2026, down 8.28 percentage points from -52.29% a year earlier but up 9.27 percentage points from the prior quarter.

Analysis

Abvc Biopharma (ABVC) Return on Equity [ROE] (2015 - 2026) Analysis & Trends

For FY2025, Abvc Biopharma's Return on Equity [ROE] came in at -119.49%, up 412.42 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a five-year change of +715.56 percentage points (FY2020 to FY2025).
  • In prior years, Abvc Biopharma's Return on Equity [ROE] was -531.91% in FY2024 (-163.02 pp), -368.89% in FY2023 (-99.41 pp), -269.48% in FY2022 (-60.75 pp) and -208.73% in FY2021 (+626.31 pp).
  • Quarterly Return on Equity [ROE] has run from a low of -806.70% in Q2 2023 to a high of -51.34% in Q3 2025 over five years.
  • On a year-over-year basis, Return on Equity [ROE] increased in five of the last eight quarters, with an average year-over-year change of +171.69 percentage points.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 1240.90 percentage points; the weakest was Q2 2023, with a drop of 603.31 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -69.84% (Q1 2026), -60.28% (Q4 2025) and -51.34% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Abvc Biopharma 27.31 Mn 29.30 Mn - -60.57%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -60.57%
Mar 31, 2026 -69.84%
Dec 31, 2025 -60.28%
Sep 30, 2025 -51.34%
Jun 30, 2025 -52.29%
Mar 31, 2025 -75.47%
Dec 31, 2024 -444.55%
Sep 30, 2024 -324.49%
Jun 30, 2024 -536.50%
Mar 31, 2024 -686.69%
Dec 31, 2023 -160.56%
Sep 30, 2023 -231.81%
Jun 30, 2023 -806.70%
Mar 31, 2023 -487.74%
Dec 31, 2022 -365.37%
Sep 30, 2022 -251.62%
Jun 30, 2022 -203.39%
Mar 31, 2022 -208.58%
Dec 31, 2021 -146.24%
Sep 30, 2021 -249.30%
API Access

Abvc Biopharma Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY